Chantix vs. Zyban: Comparing the Two Quit-Smoking Medications

If you’re weighing Chantix vs Zyban as a way to quit smoking, you’re already looking at the two most effective prescription medications available. Both outperform nicotine replacement therapy alone. Both have decades of clinical data behind them. And both work through completely different mechanisms — which means the right choice depends on your medical history, your side-effect tolerance, and in some cases, which one you can actually get your hands on.

Here’s what the evidence says about each, and how to decide between them.

What These Drugs Actually Are

Varenicline is sold as Chantix in the United States and Champix in the UK, Canada, Australia, and most of Europe. It was developed specifically for smoking cessation by Pfizer and approved in 2006. It is the only prescription medication designed from the ground up to target nicotine addiction.

Bupropion is sold as Zyban for smoking cessation and as Wellbutrin for depression. It’s an atypical antidepressant that was discovered — somewhat by accident — to reduce nicotine cravings. GlaxoSmithKline received approval for the smoking cessation indication in 1997. Generic bupropion is widely available.

Both require a prescription. Neither contains nicotine.

How Each Drug Works

Varenicline (Chantix/Champix): The Targeted Approach

Varenicline is a partial agonist at the α4β2 nicotinic acetylcholine receptor — the same receptor that nicotine binds to when you smoke or vape.

In plain terms: it partially activates the receptor, giving you a low level of dopamine release (enough to take the edge off withdrawal), while simultaneously blocking nicotine from binding fully. If you smoke while taking varenicline, the cigarette feels flat. The reward signal is muted. This dual action — partial activation plus blockade — is why it’s so effective. It reduces both the misery of not smoking and the pleasure of smoking.

For a deeper explanation of how nicotine hijacks these receptors in the first place, see our piece on how nicotine affects the brain.

Bupropion (Zyban): The Antidepressant Route

Bupropion is a norepinephrine-dopamine reuptake inhibitor (NDRI). It blocks the reabsorption of dopamine and norepinephrine in the brain, increasing the availability of both neurotransmitters.

The mechanism for smoking cessation isn’t fully understood, but the working theory is twofold: it partially compensates for the dopamine deficit that occurs during nicotine withdrawal, and it may also act as a weak antagonist at nicotinic receptors. The net effect is reduced cravings and reduced withdrawal severity — particularly the mood-related symptoms like irritability, difficulty concentrating, and depressed mood.

This matters because withdrawal isn’t just about cravings. It’s the constellation of cognitive and emotional symptoms that makes people reach for a cigarette on day three. If you’ve tried quitting before and found the mood disruption unbearable, bupropion addresses that directly. See our guide to nicotine withdrawal symptoms for what to expect.

Efficacy: What the Numbers Say

The definitive comparison comes from the EAGLES trial (Anthenelli et al., 2016), published in The Lancet. This was a randomised, double-blind, placebo-controlled trial with 8,144 participants across 140 centres in 16 countries. It compared varenicline, bupropion, nicotine patch, and placebo head-to-head.

Continuous abstinence rates (weeks 9–12):

Treatment	Abstinence Rate
Varenicline	25.5%
Bupropion	18.8%
Nicotine Patch	17.8%
Placebo	9.4%

Continuous abstinence rates (weeks 9–24):

Treatment	Abstinence Rate
Varenicline	21.8%
Bupropion	16.2%
Nicotine Patch	15.7%
Placebo	8.3%

Varenicline outperformed bupropion at every time point. It roughly tripled the odds of quitting compared to placebo, while bupropion roughly doubled them. Both beat nicotine patches, though bupropion and patches were statistically similar.

A 2016 Cochrane review by Cahill et al. pooled 14 trials directly comparing varenicline with bupropion (over 6,000 participants). The pooled risk ratio was 1.39 in favour of varenicline — meaning you’re about 40% more likely to be abstinent at six months with varenicline than bupropion.

The hierarchy is consistent across the literature: varenicline > bupropion ≈ NRT > placebo. If raw quit rates are your only criterion, varenicline wins.

But raw quit rates aren’t the only criterion.

Side Effects

Varenicline Side Effects

The most common side effect is nausea, reported by roughly 30% of users. It’s dose-related and often manageable by taking the medication with food and a full glass of water, or by extending the titration period.

Other common effects:

• Insomnia (18%)
• Abnormal dreams or vivid dreams (13%)
• Headache (15%)
• Flatulence and constipation
• Changes in taste

The psychiatric safety question. For years, varenicline carried an FDA black-box warning for neuropsychiatric events — depression, agitation, suicidal thoughts. The EAGLES trial was specifically designed to evaluate this concern. The result: no significant increase in neuropsychiatric adverse events compared to nicotine patch or placebo, even among participants with diagnosed psychiatric conditions. The FDA removed the black-box warning in 2016.

This doesn’t mean zero psychiatric risk. Individual reports of mood changes exist. But the large-scale evidence shows the risk is not elevated compared to other cessation methods.

Bupropion Side Effects

The most common side effects are insomnia (30–40%) and dry mouth (10%).

Other common effects:

• Headache
• Dizziness
• Nausea (less frequent than with varenicline)
• Agitation or restlessness
• Weight stability (bupropion is one of the few antidepressants associated with weight loss rather than gain — relevant since weight gain is a major concern for quitters)

The seizure risk. Bupropion lowers the seizure threshold. The risk is approximately 0.1% (1 in 1,000) at the standard 300mg/day dose. This rises sharply above 450mg/day, which is why that’s the hard maximum.

Contraindications: Who Should Not Take Each

Varenicline

• Severe renal impairment (dose adjustment required if GFR < 30)
• Known hypersensitivity to varenicline
• Use with caution in patients with pre-existing psychiatric conditions (though the EAGLES data is reassuring)

Bupropion

The contraindication list is longer and more restrictive:

• Seizure disorders — absolute contraindication
• Eating disorders (anorexia nervosa, bulimia) — significantly elevated seizure risk
• Abrupt discontinuation of alcohol or benzodiazepines — seizure risk
• MAO inhibitor use within 14 days
• Other bupropion-containing products (e.g., already taking Wellbutrin for depression — you cannot add Zyban on top)
• Severe hepatic impairment

The seizure contraindications are the main reason bupropion doesn’t work for everyone. If you have any history of seizures, eating disorders, or are withdrawing from alcohol, bupropion is off the table.

Who Each Medication Is Best For

Varenicline is likely the better choice if:

• You have no contraindications to either drug and want the highest statistical chance of quitting
• You’re a heavy smoker (20+ cigarettes per day) — the EAGLES trial showed the efficacy advantage was most pronounced in heavier smokers
• Nausea doesn’t particularly bother you
• You’ve tried bupropion before and it didn’t work

Bupropion is likely the better choice if:

• You have co-existing depression or anxiety — bupropion treats both the depression and the smoking simultaneously, which can be genuinely life-changing for some people
• You’re concerned about weight gain during quitting — bupropion is the only cessation medication with evidence for attenuating post-cessation weight gain
• Nausea is a dealbreaker — bupropion causes significantly less nausea than varenicline
• You can’t access varenicline (more on this below)
• You’ve tried varenicline before and the side effects were intolerable

If you’re managing depression alongside your quit attempt, the dual benefit of bupropion is hard to overstate. Quitting smoking is one of the hardest things you’ll do, and doing it while your mood is in freefall makes relapse almost inevitable. For a deeper look at why quitting is so difficult in the first place, read our piece on why quitting nicotine is so hard.

Combining With NRT

Both medications can be combined with nicotine replacement therapy, and the evidence for combination therapy is growing.

Varenicline + NRT: A 2014 Koegelenberg et al. trial in JAMA found that adding a nicotine patch to varenicline increased 12-week abstinence from 55.4% to 65.1% (and six-month abstinence from 40.0% to 48.7%). The combination was safe and well-tolerated. Some clinicians now consider this the gold standard for highly dependent smokers.

Bupropion + NRT: This is a well-established combination. The US Clinical Practice Guideline for Treating Tobacco Use recommends bupropion plus NRT as a first-line combination. Adding bupropion to a nicotine patch addresses both the neurochemical and behavioural aspects of withdrawal. Our complete NRT guide covers the different forms available and how to use them properly.

Varenicline + bupropion: Some studies have explored combining the two prescription medications. A 2014 Ebbert et al. trial in JAMA found no significant benefit of adding bupropion to varenicline. The combination increased insomnia and anxiety without improving quit rates. Current evidence doesn’t support this combination.

The Chantix/Champix Discontinuation Problem

In 2021, Pfizer voluntarily recalled all lots of Chantix (and Champix internationally) due to the presence of N-nitroso-varenicline above acceptable levels. N-nitroso compounds are potential carcinogens, and the levels detected exceeded FDA and EMA limits for daily intake.

Pfizer initially suggested this was temporary. It wasn’t. As of 2025, Pfizer has not resumed manufacturing branded Chantix or Champix. The brand names are effectively discontinued.

Generic varenicline has entered the market in some countries. In the United States, generic versions received FDA approval and have been sporadically available from manufacturers including Apotex and Par Pharmaceutical. However, supply has been inconsistent. In the UK, generic varenicline has faced similar availability challenges, with the NHS reporting intermittent stock issues.

The practical reality: depending on when and where you’re reading this, varenicline may or may not be available at your local pharmacy. This is not a minor inconvenience — it’s a genuine barrier for the medication that the evidence says works best. Check with your prescriber about current availability in your area.

Bupropion, by contrast, has been available as a generic for decades. Supply is stable and consistent worldwide.

Cost Considerations

Costs vary enormously by country and insurance status, but the general picture:

Varenicline: A standard 12-week course costs approximately £150–£250 in the UK (when available via private prescription) and $400–$600 in the US without insurance. Generic versions are cheaper but availability is the constraint. In the UK, if your GP prescribes it and stock is available, you pay the standard NHS prescription charge.

Bupropion (Zyban): A 7–9 week course runs approximately £80–£150 in the UK and $150–$400 in the US without insurance. Generic bupropion is significantly cheaper — often under $50 for a month’s supply with insurance in the US.

Both medications are vastly cheaper than continuing to smoke. Our savings calculator can show you exactly how much you’re burning each month.

Standard Dosing Protocols

Varenicline

Period	Dose	Frequency
Days 1–3	0.5mg	Once daily
Days 4–7	0.5mg	Twice daily
Day 8 onwards	1mg	Twice daily
Total course		12 weeks (may extend to 24)

Set your quit date for day 8 — the first day at full dose. Some clinicians allow a flexible quit window between days 8 and 35.

Bupropion (Zyban)

Period	Dose	Frequency
Days 1–6	150mg	Once daily (morning)
Day 7 onwards	150mg	Twice daily (morning + early afternoon)
Total course		7–12 weeks

Start bupropion 1–2 weeks before your quit date. It needs time to reach therapeutic blood levels. The quit date falls during week two of treatment.

Take the second dose no later than mid-afternoon to minimise insomnia.

What About Going Unmedicated?

These are powerful tools, but they’re not the only path. Many people quit successfully without any medication — cold turkey remains effective and is the most common method used by successful long-term quitters. The best method is the one you’ll actually follow through on. If you want a broader overview of all approaches, our complete guide to quitting smoking covers every evidence-based option.

The point of medications isn’t that you need them. It’s that they improve your odds, and if you’ve tried quitting before and struggled, they can make the difference between another failed attempt and the one that sticks.

FAQ

Can I take Chantix and Zyban together?

Current evidence doesn’t support combining varenicline and bupropion. A 2014 JAMA trial (Ebbert et al.) found no improvement in quit rates when bupropion was added to varenicline, but side effects — particularly insomnia and anxiety — increased. Your prescriber may have specific reasons for considering it, but it’s not standard practice.

Is Zyban the same as Wellbutrin?

Same active ingredient (bupropion hydrochloride), same molecule, but different approved indications and sometimes different formulations. Zyban is approved for smoking cessation at 150mg twice daily. Wellbutrin is approved for depression at doses up to 450mg/day. If you’re already taking Wellbutrin, you cannot add Zyban — the combined dose would exceed safe limits and dramatically increase seizure risk. Talk to your prescriber about using your existing Wellbutrin prescription for cessation support.

Is generic Chantix available?

Generic varenicline has received regulatory approval in the US, UK, and several other markets. However, real-world availability has been unreliable since Pfizer’s 2021 recall. Some pharmacies carry it; many don’t. Supply fluctuates month to month. Contact your pharmacy or prescriber to check current stock before counting on it as your quit plan.

Do these medications work for vaping?

Neither varenicline nor bupropion has been specifically approved for vaping cessation, and the clinical trial data is primarily from cigarette smokers. However, the pharmacology is the same — vaping delivers nicotine to the same receptors that varenicline targets, and the withdrawal neurochemistry that bupropion modifies is identical. Some clinicians prescribe these medications off-label for vaping cessation, and early evidence is promising. Discuss it with your doctor.

How long do I need to take them?

Standard courses are 12 weeks for both medications. Evidence supports extending varenicline to 24 weeks for higher-risk patients — a 2015 Tonstad et al. trial showed that extended treatment reduced relapse rates. Bupropion can also be extended, particularly if it’s also managing depression. Do not stop either medication abruptly without discussing it with your prescriber.

Can I use NRT at the same time as these medications?

Yes, in most cases. Combining a nicotine patch with either medication has evidence supporting improved outcomes. This should be done under medical supervision. See the combination therapy section above for specific trial data.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Varenicline and bupropion are prescription medications with specific contraindications, drug interactions, and monitoring requirements. Do not start, stop, or change any medication without consulting your prescriber. The dosing information provided here is general — your doctor may adjust based on your individual health profile.

The Bottom Line

Varenicline is the more effective medication by a clear margin. Bupropion is the more accessible one, with stable supply, a longer track record, fewer gastrointestinal side effects, and a dual benefit for people managing depression. Both significantly improve your odds compared to quitting unassisted.

The best medication is the one your doctor recommends based on your specific circumstances — and the one you can actually obtain and tolerate for the full course. Whichever route you take, combining medication with behavioural support produces better outcomes than medication alone.

If you’re building your quit plan and want structured support alongside medication, join Cravo. We’re building an app that helps you through the psychological side of quitting — the triggers, the habits, the identity shift — so the medication can do its job on the neurochemistry while you handle the rest.

“The best quit method is the one you’ll actually complete. Medication improves your odds. Following through is what changes your life.” — Cravo